DaVita Inc (DVA) Files 10-K for the Fiscal Year Ended on December 31, 2018

DaVita Inc (DVA, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. DaVita Inc is engaged in operating kidney dialysis centers and providing related lab services in dialysis centers and in contracted hospitals across USA. It also operates other ancillary services and strategic initiatives. DaVita Inc has a market cap of $9.77 billion; its shares were traded at around $58.69 with a P/E ratio of 74.30 and P/S ratio of 0.89. DaVita Inc had annual average EBITDA growth of 10.40% over the past ten years. GuruFocus rated DaVita Inc the business predictability rank of 3-star.

For the last quarter DaVita Inc reported a revenue of $2.8 billion, compared with the revenue of $2.8 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $11.4 billion, an increase of 4.9% from last year. For the last five years DaVita Inc had an average revenue decline of 1.6% a year.

The reported diluted earnings per share was 92 cents for the year, a decline of 73.5% from the previous year. Over the last five years DaVita Inc had an average EPS decline of 12% a year. The DaVita Inc had a decent operating margin of 13.07%, compared with the operating margin of 14.89% a year before. The 10-year historical median operating margin of DaVita Inc is 15.52%. The profitability rank of the company is 7 (out of 10).

At the end of the fiscal year, DaVita Inc has the cash and cash equivalents of $323.0 million, compared with $508.2 million in the previous year. The long term debt was $8.2 billion, compared with $9.2 billion in the previous year. The interest coverage to the debt is 3.1. DaVita Inc has a financial strength rank of 4 (out of 10).

At the current stock price of $58.69, DaVita Inc is traded at 23.6% discount to its historical median P/S valuation band of $76.82. The P/S ratio of the stock is 0.89, while the historical median P/S ratio is 1.16. The intrinsic value of the stock is $47.88 a share, according to GuruFocus DCF Calculator. The stock lost 18.39% during the past 12 months.

For the complete 20-year historical financial data of DVA, click here.